C. difficile Infection Management in Cancer Patients
Initial Assessment and Workup
- For a patient with squamous cell carcinoma on chemoradiation who develops diarrhea after taking Augmentin, a stool workup for C. difficile should be performed immediately, along with complete blood count and electrolyte profile, as this represents a complicated case requiring aggressive management 1
- Obtain detailed history of diarrhea onset and duration in relation to Augmentin administration, and document number of stools and stool composition (watery, presence of blood, nocturnal episodes) 2
- Assess for fever, dizziness, abdominal pain/cramping, or weakness (to rule out sepsis, bowel obstruction, dehydration) 2
- Review medication profile (chemoradiation agents, Augmentin, other medications) 2
- Evaluate dietary factors that may exacerbate diarrhea 2
C. difficile Workup Protocol
- Perform stool testing for C. difficile toxin as part of comprehensive stool workup 1
- Include testing for blood, fecal leukocytes, and other infectious agents (Salmonella, E. coli, Campylobacter) 3
- Check electrolyte profile to evaluate dehydration status 3
Management and Supportive Care
- Consider octreotide (100-150 μg SC TID or IV 25-50 μg/hr) if diarrhea is severe and patient is dehydrated 3, 4
- Administer IV fluids for dehydration 3
- Implement dietary modifications (eliminate lactose-containing products, alcohol, high-osmolar supplements) 2
- Encourage 8-10 large glasses of clear liquids daily (Gatorade, broth) 2
- Recommend small, frequent meals (bananas, rice, applesauce, toast, plain pasta) 2
- Consider temporary interruption of chemoradiation until symptoms resolve 2